Patient-Derived Xenograft Models in Cancer Research

by Wytske M. van Weerden
Published 2021-02-01

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research

by Eline A.M. Ruigrok, Wytske M. van Weerden, Julie Nonnekens, Marion de Jong
Published 2019-10-01

Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.

by Rute B Marques, Natasja F Dits, Sigrun Erkens-Schulze, Wytske M van Weerden, Guido Jenster
Published 2010-10-01

Apalutamide Sensitizes Prostate Cancer to Ionizing Radiation via Inhibition of Non-Homologous End-Joining DNA Repair

by Wenhao Zhang, Chen-Yi Liao, Hajar Chtatou, Luca Incrocci, Dik C. van Gent, Wytske M. van Weerden, Julie Nonnekens
Published 2019-10-01

Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.

by Rute B Marques, Natasja F Dits, Sigrun Erkens-Schulze, Wilfred F J van Ijcken, Wytske M van Weerden, Guido Jenster
Published 2011-01-01

Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor

by Mahmoud Hassani, Fatemeh Hajari Taheri, Zahra Sharifzadeh, Arash Arashkia, Jamshid Hadjati, Wytske M. van Weerden, Shahriyar Abdoli, Mohammad Hossein Modarressi, Mohsen Abolhassani
Published 2020-03-01

Engineered Jurkat Cells for Targeting Prostate-Specific Membrane Antigen on Prostate Cancer Cells by Nanobody-Based Chimeric Antigen Receptor

by Mahmoud Hassani, Fatemeh Hajari Taheri, Zahra Sharifzadeh, Arash Arashkia, Jamshid Hadjati, Wytske M. van Weerden, Shahriyar Abdoli, Mohammad Hossein Modarressi, Mohsen Abolhassani
Published 2020-03-01

Overexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.

by Delila Gasi, Hetty A van der Korput, Hannie C Douben, Annelies de Klein, Corrina M de Ridder, Wytske M van Weerden, Jan Trapman
Published 2011-01-01

Characterization of Heterogeneous Prostate Tumors in Targeted Pten Knockout Mice.

by Hanneke Korsten, Angelique C J Ziel-van der Made, Wytske M van Weerden, Theo van der Kwast, Jan Trapman, Petra W Van Duijn
Published 2016-01-01

The CHK1 inhibitor MU380 significantly increases the sensitivity of human docetaxel‐resistant prostate cancer cells to gemcitabine through the induction of mitotic catastrophe

by Stanislav Drápela, Prashant Khirsariya, Wytske M. vanWeerden, Radek Fedr, Tereza Suchánková, Diana Búzová, Jan Červený, Aleš Hampl, Martin Puhr, William R. Watson, Zoran Culig, Lumír Krejčí, Kamil Paruch, Karel Souček
Published 2020-10-01

NanoBiT System and Hydrofurimazine for Optimized Detection of Viral Infection in Mice—A Novel in Vivo Imaging Platform

by Natasa Gaspar, Giorgia Zambito, Iris J. C. Dautzenberg, Steve J. Cramer, Rob C. Hoeben, Clemens Lowik, Joel R. Walker, Thomas A. Kirkland, Thomas P. Smith, Wytske M. van Weerden, Jeroen de Vrij, Laura Mezzanotte
Published 2020-08-01

AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel

by Anieta M. Sieuwerts, Wendy Onstenk, Jaco Kraan, Corine M. Beaufort, Mai Van, Bram De Laere, Luc Y. Dirix, Paul Hamberg, Aart Beeker, Hielke J. Meulenbeld, Geert‐Jan Creemers, Wytske M. vanWeerden, Guido W. Jenster, Annemieke J. M. Nieuweboer, Ron H. J. Mathijssen, Ronald deWit, John W. M. Martens, Stefan Sleijfer
Published 2019-08-01